Investing Profile

Doug Cole

VCInvestor
Managing Partner at Flagship Pioneering
flagshippioneering.com/people...Cambridge, Massachusetts
Photo of Doug Cole, Managing Partner at Flagship Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Dartmouth College Network
80 CONNECTIONS
cb
Flagship Ventures Managing Partner
$100K - $5.0M
$1.5M
38
$824M
CompanyStageDateRound SizeTotal Raised
Harbinger Health
Series BSep 2023$140M
Series ADec 2021$50M
$190M
Empress Therapeutics
Series UnknownJun 2023$50M
$50M
Co-investors: Noubar Afeyan (Flagship Ventures)
Vesalius Therapeutics
Series AMar 2022$75M
$75M
Co-investors: Noubar Afeyan (Flagship Ventures)
Repertoire Immune Medicines
Series BApr 2021$190M
Series ANov 2017$25M
$210M
Co-investors: Katie Ellias (T1D Fund)
Sigilon Therapeutics
Series BMar 2020$80M
$80M
Foghorn Therapeutics
Series UnknownMar 2018$50M
$50M
YourBio Health
Series CNov 2016$10M
Series BAug 2014$16M
Series AJun 2012$10M
Series AMay 2011$5M
$41M
Co-investors: Alan Crane (Polaris Partners)
Denali Therapeutics
Series BAug 2016$130M
Series AMay 2015$220M
$350M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Robert Nelsen (ARCH Venture Partners)
Intern in Internal Medicine, Osler Medical Service Johns Hopkins HospitalPresent
Resident in Neurology Massachusetts General HospitalPresent
Fellow in Neurology Massachusetts General HospitalPresent
Instructor in Neurology Harvard Medical SchoolPresent
Assistant in Neurology Massachusetts General HospitalPresent
Medical Director Cytotherapeutics, Inc.Present
Program Executive Vertex PharmaceuticalsPresent
General Partner Flagship VenturesPresent
University of Pennsylvania School of Medicine Doctor of Medicine (M.D.)
Dartmouth College AB magna cum laude English